Research Interest: Drug Discovery
Name | PhD Program | Research Interest | Publications |
---|---|---|
Frankowski, Kevin WEBSITE PUBLICATIONS |
PHD PROGRAM RESEARCH INTEREST |
We are inspired by the diversity and complexity found in natural products and use their architecture as both a platform for developing chemical methods and as scaffolds for new molecular tools in chemical biology. We have employed our chemical synthesis skill set to solve emerging challenges facing modern medicine. This has led to ongoing collaborative projects in metastatic cancer, hepatitis C antivirals, dopamine signaling and sigma receptor ligands. Of particular interest is the development of next generation anti-metastasis agents to our recent phase I clinical candidate, metarrestin. |
Silva, Harry |
PHD PROGRAM RESEARCH INTEREST |
|
Ssengonzi, Rebecca |
PHD PROGRAM RESEARCH INTEREST |
|
Soden, Gaby |
PHD PROGRAM RESEARCH INTEREST |
|
Smyers, Nate |
PHD PROGRAM RESEARCH INTEREST |
|
Liu, Tongkun (Louis) |
PHD PROGRAM RESEARCH INTEREST |
|
Gilley, Kristen |
PHD PROGRAM RESEARCH INTEREST |
|
de Castro, Sagan |
PHD PROGRAM RESEARCH INTEREST |
|
Brache, Christopher |
PHD PROGRAM RESEARCH INTEREST |
|
Sheahan, Tim WEBSITE PUBLICATIONS |
PHD PROGRAM RESEARCH INTEREST |
Dr. Sheahan is an expert virologist with a primary appointment in the Department of Epidemiology in the Gillings School of Global Public Health and a secondary appointment in Microbiology and Immunology in the School of Medicine. His research is focused on understanding emerging viral diseases and developing new means to stop them with a current focus on coronavirus and hepacivirus. |